Key Updates
RGTI has declined 8.70% since the September 25, 2026 report, moving from approximately $17.24 to $15.74, erasing the majority of the prior surge. This pullback occurs despite the company being included in a $300 million CHIPS Act funding deal in which the U.S. government acquired minority stakes in D-Wave, Rigetti, and Quantinuum, as reported by The Wall Street Journal and Morningstar on September 8, 2026. The stock's YTD performance remains deeply negative at -28.94%, and the price has now retraced to levels near the early September range, suggesting the recent rally was not sustained by fresh company-specific catalysts.
Current Trend
RGTI is trading at $15.74, down 28.94% year-to-date. The 6-month performance shows a gain of 22.02%, indicating a significant recovery from earlier lows, but the stock has given back 8.70% since the last report. The 1-month performance is nearly flat at +0.51%, while the 5-day trend is negative at -1.66%. The stock appears to be consolidating in a range roughly between $15.65 (the September 9 level) and $17.24 (the September 25 peak). A break below the $15.65 support level could signal further downside toward the YTD lows, while a move above $17.24 would be needed to confirm a resumption of the uptrend.
Investment Thesis
The investment thesis for RGTI is centered on the company's position in the quantum computing sector and its eligibility for government support. The most significant development is the U.S. government's acquisition of minority stakes in Rigetti, D-Wave, and Quantinuum as part of a $300 million CHIPS Act funding deal, which provides both financial backing and validation of the company's strategic importance. However, the lack of fresh company-specific news since September 25, combined with the stock's significant YTD decline, suggests that the market is still weighing the long-term commercial viability of quantum computing against the current lack of substantial revenue generation. The partnership between CGI and D-Wave Quantum (September 23) highlights growing enterprise adoption in the sector but does not directly involve Rigetti.
Thesis Status
The thesis remains neutral-to-cautiously positive but is under pressure. The CHIPS Act funding deal provides a strong fundamental catalyst, as government involvement reduces some technology and funding risks. However, the stock's inability to hold gains above the $17 level and the pronounced YTD decline suggest that investor sentiment remains fragile. The recent price action indicates that the market is not yet pricing in a clear path to profitability or commercial scale for Rigetti specifically, despite the favorable sector tailwinds. The thesis is intact but requires additional positive catalysts, such as new customer announcements or technological milestones, to regain upward momentum.
Key Drivers
- U.S. government minority stake in Rigetti via the $300 million CHIPS Act funding deal (September 8, 2026) — a significant validation of the company's role in national quantum strategy. Source
- Enterprise quantum adoption momentum, as evidenced by CGI and D-Wave Quantum partnership (September 23, 2026), which signals growing commercial interest in quantum solutions, though not directly tied to Rigetti. Source
- Sector-wide competition from AI-driven chip design startups, such as Ricursive Intelligence, which raised $335 million at a $4 billion valuation with Nvidia backing, potentially diverting investor attention from quantum hardware plays. Source
Technical Analysis
RGTI is currently trading at $15.74, down 8.70% from the recent high of $17.24. The stock has established a short-term trading range with support at approximately $15.65 (the September 9 level) and resistance at $17.24 (the September 25 peak). The 5-day decline of -1.66% and the flat 1-month performance indicate a lack of directional conviction. The YTD decline of -28.94% remains a dominant bearish factor, although the 6-month gain of +22.02% suggests a broader recovery pattern. The current price action is best characterized as a pullback within a consolidation phase. A decisive move below $15.65 would likely trigger further selling, while a close above $17.24 would signal a breakout and potentially resume the uptrend.
Bull Case
- U.S. government's minority stake in Rigetti through the CHIPS Act funding provides strategic validation and potential for future government contracts. Source
- The 6-month price gain of +22.02% demonstrates that the stock has been able to recover strongly from lower levels, indicating underlying buyer interest. Source
- Growing enterprise quantum adoption, as seen in the CGI-D-Wave partnership, suggests the overall market for quantum computing is expanding, which could benefit Rigetti in the long term. Source
- The CHIPS Act funding deal is a concrete financial commitment from the government, reducing some funding uncertainty for Rigetti's development pipeline. Source
- The stock's ability to surge 10.17% in the prior period, as noted in the September 25 report, demonstrates that positive sentiment can drive significant short-term rallies. Source
Bear Case
- The stock is down 28.94% year-to-date, indicating persistent negative investor sentiment and a lack of confidence in near-term fundamentals. Source
- The 8.70% decline since the last report shows that the recent rally was not sustainable, and the stock has failed to hold gains above the $17 level. Source
- The partnership between CGI and D-Wave Quantum highlights that competitors are securing enterprise partnerships, potentially leaving Rigetti behind in commercial adoption. Source
- The rise of AI-driven chip design companies like Ricursive Intelligence, with significant funding ($335 million) and backing from Nvidia, could shift investor focus and capital away from quantum computing hardware companies like Rigetti. Source
- The flat 1-month performance (+0.51%) and negative 5-day trend (-1.66%) suggest that there is no immediate catalyst to drive the stock higher, and momentum is fading. Source